How have WGSWW shares performed in 2024?

GeneDx's stock was trading at $0.01 at the beginning of 2024. Since then, WGSWW shares have increased by 164.9% and is now trading at $0.0265. View the best growth stocks for 2024 here .

Are investors shorting GeneDx?

GeneDx saw a increase in short interest in May. As of May 15th, there was short interest totaling 3,900 shares, an increase of 77.3% from the April 30th total of 2,200 shares. Based on an average daily trading volume, of 62,000 shares, the short-interest ratio is currently 0.1 days. View GeneDx's Short Interest .

How do I buy shares of GeneDx?

Shares of WGSWW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:WGSWW

GeneDx (WGSWW) Stock Price, News & Analysis

→ Dems have chosen Biden replacement? (From Paradigm Press) (Ad)

Free WGSWW Stock Alerts

$0.03

+0.01 (+60.64%)

(As of 05/31/2024 ET)

Compare

Today's Range: $0.02
▼
$0.03
50-Day Range: $0.02
▼
$0.06
52-Week Range: $0.00
▼
$0.10

Volume: 8,338 shs
Average Volume: 68,510 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials SEC Filings Short Interest Trends

Get GeneDx alerts:

Ad Paradigm Press

Dems have chosen Biden replacement?

On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.

See who it is HERE.

About GeneDx

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.

WGSWW Stock Price History

30 days | 90 days | 365 days | Advanced Chart

WGSWW Stock News Headlines

May 30 at 4:10 AM | americanbankingnews.com

Short Interest in GeneDx Holdings Corp. (NASDAQ:WGSWW) Expands By 77.3%

May 1, 2024 | finance.yahoo.com

GeneDx Holdings First Quarter 2024 Earnings: Beats Expectations

April 28, 2024 | finance.yahoo.com

GeneDx Holdings Corp. (WGSWW)

See More Headlines

Receive WGSWW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GeneDx and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Health Information Services
Sub-Industry: N/A
Current Symbol: NASDAQ:WGSWW
CUSIP: N/A
CIK: 1818331
Web: www.genedx.com
Phone: 800-298-6470
Fax: N/A
Employees: 1,000
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $221.85 million
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

Ms. Katherine A. Stueland (Age 48)
President, CEO & Director
Comp: $1.19M
Mr. Kevin Feeley
Chief Financial Officer
Ms. Karen Ponchner
Senior VP & Head of Operations
Mr. Eric Olivares Ph.D.
Chief Product & Technology Officer
Mr. Devin K. Schaffer J.D.
M.B.A., General Counsel
Mr. Paul Kruszka M.D.
Chief Medical Officer
Ms. Melanie Duquette
Chief Growth Officer
Sabrina Dunbar
Chief of Staff

Key Competitors

View All Competitors

WGSWW Stock Analysis - Frequently Asked Questions

How have WGSWW shares performed in 2024?: GeneDx's stock was trading at $0.01 at the beginning of 2024. Since then, WGSWW shares have increased by 164.9% and is now trading at $0.0265.
View the best growth stocks for 2024 here.
Are investors shorting GeneDx?: GeneDx saw a increase in short interest in May. As of May 15th, there was short interest totaling 3,900 shares, an increase of 77.3% from the April 30th total of 2,200 shares. Based on an average daily trading volume, of 62,000 shares, the short-interest ratio is currently 0.1 days.
View GeneDx's Short Interest.
How do I buy shares of GeneDx?: Shares of WGSWW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:WGSWW) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial